Interestingly, PIK3/AKT signaling cascade is specifically targeted by the onco-suppressor miR-126, as it is well documented that IRS-1 and PIK3R2, two upstream components of this pathway, are directly inhibited by miR-126 in several cancer types, including BC [22,27,28]. This evidence concerns the gene PIK3CG and breast cancer.